| CAS ID: | P09919 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Protein based biotech |
| Natural Product: | No |
| Other Names: | |
| Analysis: | N/A |
Trial Record 1
| ClinicalTrial ID | NCT02642003 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | December 30, 2015 | Last Verified | October 18, 2016 |
| Sponsor | Sir Ganga Ram Hospital | ||
Trial Record 2
| ClinicalTrial ID | NCT02451033 | Disease | Liver fibrosis |
| Phase | Phase 2,Phase 3 | Status | Completed |
| First Received | May 21, 2015 | Last Verified | August 29, 2017 |
| Sponsor | Postgraduate Institute of Medical Education and Research | ||
Trial Record 3
| ClinicalTrial ID | NCT01902511 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | July 18, 2013 | Last Verified | November 22, 2016 |
| Sponsor | Institute of Liver and Biliary Sciences, India | ||
Trial Record 4
| ClinicalTrial ID | NCT01503749 | Disease | Liver fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | January 4, 2012 | Last Verified | December 19, 2014 |
| Sponsor | Seoul National University Hospital | ||
Trial Record 5
| ClinicalTrial ID | NCT03123666 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Recruiting |
| First Received | April 21, 2017 | Last Verified | May 11, 2018 |
| Sponsor | Institute of Liver and Biliary Sciences, India | ||
Trial Record 6
| ClinicalTrial ID | NCT02855632 | Disease | Scar |
| Phase | Not Applicable | Status | Recruiting |
| First Received | August 4, 2016 | Last Verified | January 5, 2018 |
| Sponsor | Sir Run Run Shaw Hospital | ||